Inflammatory bowel disease in the dog: Differences and similarities with humans

被引：98

作者：

Cerquetella, Matteo ^{[2
]}

Spaterna, Andrea ^{[2
]}

Laus, Fulvio ^{[2
]}

Tesei, Beniamino ^{[2
]}

Rossi, Giacomo ^{[2
]}

Antonelli, Elisabetta ^{[1
]}

Villanacci, Vincenzo ^{[3
]}

Bassotti, Gabrio ^{[1
]}

机构：

[1] Santa Maria Misericordia Hosp, Dept Clin & Expt Med, Gastroenterol & Hepatol Sect, I-06153 Perugia, Italy

[2] Univ Camerino, Sch Med Vet Sci, I-62024 Matelica, Macerata, Italy

[3] Spedali Civil Brescia, Dept Pathol 2, I-25100 Brescia, Italy

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2010年 / 16卷 / 09期

关键词：

Colitis; Dog; Inflammatory bowel diseases; TOLL-LIKE RECEPTORS; HISTIOCYTIC ULCERATIVE-COLITIS; MESSENGER-RNA EXPRESSION; CHRONIC ENTEROPATHIES; GASTROINTESTINAL-TRACT; INTESTINAL INFLAMMATION; CANINE INTESTINE; DUODENAL MUCOSA; CROHNS-DISEASE; GUT MICROBIOTA;

D O I：

10.3748/wjg.v16.i9.1050

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Inflammatory bowel diseases (IBD) represent important chronic conditions affecting the gastrointestinal tract in man. However, similar disorders are found in several animal species and the IBD affecting dogs are particularly important. These are encompassed by an umbrella of probably several different entities with common symptoms, some of which seem to share striking similarities with human conditions. This review will focus on the actual knowledge of IBD in dogs, and attempt to identify differences and similarities with human IBD conditions. (C) 2010 Baishideng. All rights reserved.

引用

页码：1050 / 1056

页数：7

共 89 条

[51]

Loftus EV, 2007, REV GASTROENTEROL DI, V7, pS8

[52]

Luckschander N, 2006, J VET INTERN MED, V20, P221, DOI 10.1892/0891-6640(2006)20[221:PACAAR]2.0.CO

[53]

[54] Activation of nuclear factor-κB in dogs with chronic enteropathies [J].

Luckschander, Nicole ;

Hall, Jean A. ;

Gaschen, Frederic ;

Forster, Ursula ;

Wenzlow, Nanny ;

Hermann, Pascal ;

Allenspach, Karin ;

Dobbelaere, Dirk ;

Burgener, Iwan A. ;

Welle, Monika .

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2010, 133 (2-4) :228-236

[55] The Gut Microbiota in Inflammatory Bowel Disease [J].

Macfarlane, G. T. ;

Blackett, K. L. ;

Nakayama, T. ;

Steed, H. ;

Macfarlane, S. .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) :1528-1536

[56] Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease [J].

McCann, T. M. ;

Ridyard, A. E. ;

Else, R. W. ;

Simpson, J. W. .

JOURNAL OF SMALL ANIMAL PRACTICE, 2007, 48 (11) :619-624

[57]

Mendoza J. L., 2007, Current Pharmacogenomics, V5, P235, DOI 10.2174/157016007781669213

[58] Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question [J].

Neurath, MF ;

Finotto, S ;

Fuss, I ;

Boirivant, M ;

Galle, PR ;

Strober, W .

TRENDS IN IMMUNOLOGY, 2001, 22 (01) :21-26

[59]

Nikoopour Enayat, 2008, Inflammation & Allergy Drug Targets, V7, P203, DOI 10.2174/187152808785748155

[60] Update on genetics in inflammatory disease [J].

Noomen, Casper G. ;

Hommes, Daniel W. ;

Fidder, Herma H. .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2009, 23 (02) :233-243

← 1 2 3 4 5 6 7 8 9 →